(57) ABSTRACT A transcutaneous immunization System where the topical application of an
adjuvant and an antigen or nucleic acid encoding for an antigen, to intact skin induces a …

Disclosed and claimed are methods of non-invasive immunization and drug delivery in an
animal and/or methods of inducing a systemic immune or therapeutic response in an animal …

CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O [C@ H] 1 [C@
H](O)[C@@ H](CO) O [C@@] 1 (CO) O [C@@ H] 1 [C@ H](O)[C@@ H](O)[C@ H](O)[C …

The present invention relates to techniques of skin-targeted non-invasive gene delivery to
elicit immune responses and uses thereof. The invention further relates to methods of non …

2008-11-05 Assigned to THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS
REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN …

US7951585B2 - Construction of oncolytic adenovirus recombinant specifically expressing
immune modulatory factor GM-CSF in tumor cells and uses thereof - Google Patents …

(57) ABSTRACT A transcutaneous immunization system delivers antigen to immune cells
through the skin, and induces an immune response in an animal or human. For example …

SSA EY'S, RN New England Biolab product description for pMAL System, prod ssss uct No.
Hi800. cation No. 60/133,868, filed on May 12, 1999, pro-Swiss Prot Accession No. P10845 …

(57) ABSTRACT Correspondence Address: MORGAN LEWIS & BOCKUS LLP A protein-in-
adhesive patch for transcutaneous immuniza 1111 PENNSYLVANIAAVENUE NW tion is …

2024-01-02 Assigned to INFINITY SA LLC, AS PURCHASER AGENT reassignment
INFINITY SA LLC, AS PURCHASER AGENT SECURITY INTEREST (SEE DOCUMENT FOR …